U.S. Markets for Cardiac and Vascular Tissue Engineering Products

Tissue engineering involves applying engineering principles to the study, modification, and regeneration of tissues in order to perform specific biochemical functions within an artificially created support system. This report provides an analysis of the potential United States (U.S.) market for cardiac and vascular tissue-engineered products, which comprises heart valves and vascular grafts as well as technologies for myocardial tissue regeneration, therapeutic angiogenesis, and restenosis prevention.

Due to the potentially large number of patients who may be helped by tissue engineering and cell transplantation products/technologies under development for cardiac and vascular indications, as well as the major healthcare costs associated with existing treatments, the potential dollar volume for the cardiac and vascular products market is substantial, with many applications representing multibillion-dollar opportunities. In the U.S., the total potential market for tissue engineering and cell transplantation products/technologies for cardiac and vascular indications is expected to exceed $22.8 billion in the year 2019. Although the current developing market is at a fraction of its potential, advances in the understanding of genetics and cell therapy are expected to drive this market over the forecast period covered by this report.